|
ZMYM5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.806700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.897800E-03 |
| Normal-vs-Stage2 |
3.90359999999923E-05 |
| Normal-vs-Stage3 |
1.115980E-03 |
| Normal-vs-Stage4 |
7.431900E-04 |
| Stage1-vs-Stage2 |
8.598400E-03 |
| Stage1-vs-Stage3 |
2.149400E-01 |
| Stage1-vs-Stage4 |
1.605030E-01 |
| Stage2-vs-Stage3 |
1.330040E-01 |
| Stage2-vs-Stage4 |
1.719600E-01 |
| Stage3-vs-Stage4 |
8.496400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.193500E-04 |
| Normal-vs-AfricanAmerican |
3.291800E-01 |
| Normal-vs-Asian |
4.843600E-02 |
| Caucasian-vs-AfricanAmerican |
1.749820E-01 |
| Caucasian-vs-Asian |
3.495400E-01 |
| AfricanAmerican-vs-Asian |
5.353000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.783800E-04 |
| Normal-vs-Female |
7.952100E-04 |
| Male-vs-Female |
7.488800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.764200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.754400E-04 |
| Normal-vs-Age(61-80Yrs) |
3.52369999999658E-05 |
| Normal-vs-Age(81-100Yrs) |
4.549700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.333630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.315200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.124400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.661440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.211800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.863000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.886100E-02 |
| Classical-VS-Follicular |
2.285599999996E-05 |
| Classical-VS-Other |
5.873000E-01 |
| Classical-VS-Normal |
1.904190E-02 |
| Tall-VS-Follicular |
1.855600E-01 |
| Tall-VS-Other |
7.779400E-01 |
| Tall-VS-Normal |
2.063700E-03 |
| Follicular-VS-Other |
4.171200E-01 |
| Follicular-VS-Normal |
3.8294999999966E-06 |
| Other-VS-Normal |
1.756440E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.36319999999957E-05 |
| Normal-vs-N1 |
7.642100E-02 |
| N0-vs-N1 |
7.400500E-02 |
|
|
